| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |